Last update 08 May 2025

BP-13656

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
+ [1]
Target
H3 receptor
Action
antagonists
Mechanism
H3 receptor antagonists(Histamine H3 receptor antagonists)
Therapeutic Areas
Nervous System DiseasesCardiovascular Diseases
Active Indication
Post-stroke Fatigue
Inactive Indication
Alcohol Use DisorderAlcoholismFatigue+ [1]
Originator Organization
Bioprojet Pharma SARLBioprojet Pharma SARL
Active Organization
Bioprojet Pharma SARLBioprojet Pharma SARL
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with BP-13656
NCT05240560
/ TerminatedPhase 2
A Multisite Randomized Clinical Trial Evaluating Efficacy and Safety of BP1.3656 vs Placebo in Patients With Fatigue Following Ischemic Stroke
NCT04727086
/ CompletedPhase 2IIT
Role of BP1.3656 on Alcohol Responses
NCT03424824
/ CompletedPhase 2
A Multisite Randomized Clinical Trial Evaluating BP1.3656 Vs Placebo For Alcohol Use Disorder Treatment
100 Clinical Results associated with BP-13656
Login to view more data
100 Translational Medicine associated with BP-13656
Login to view more data
100 Patents (Medical) associated with BP-13656
Login to view more data
100 Deals associated with BP-13656
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Post-stroke FatiguePhase 2
France
Bioprojet Pharma SARLBioprojet Pharma SARL
27 Apr 2023
Alcohol Use DisorderPhase 2
Russia
Bioprojet Pharma SARLBioprojet Pharma SARL
09 Jan 2018
Alcohol Use DisorderPhase 2
Bulgaria
Bioprojet Pharma SARLBioprojet Pharma SARL
09 Jan 2018
Alcohol Use DisorderPhase 2
France
Bioprojet Pharma SARLBioprojet Pharma SARL
09 Jan 2018
AlcoholismPhase 2
Netherlands
Bioprojet Pharma SARLBioprojet Pharma SARL
19 Jun 2017
FatiguePhase 1
Switzerland
Bioprojet Pharma SARLBioprojet Pharma SARL
20 Jan 2023
FatiguePhase 1
France
Bioprojet Pharma SARLBioprojet Pharma SARL
20 Jan 2023
Ischemic strokePhase 1
France
Bioprojet Pharma SARLBioprojet Pharma SARL
20 Jan 2023
Ischemic strokePhase 1
Switzerland
Bioprojet Pharma SARLBioprojet Pharma SARL
20 Jan 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free